Concepedia

Anna Galkin

AG

17

Publications

1.3K

Citations

15

H-Index

2004

Active since

Affiliations

University of Helsinki(Current)

Åbo Akademi University

Drug Discovery Laboratory (Norway)

Genomics Institute of the Novartis Research Foundation

Cedars-Sinai Medical Center

Anna Galkin is an author at University of Helsinki specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicineBiochemistryPharmacologyCell BiologyMembrane TransportTumor BiologyNatural SciencesCell SignalingCell PhysiologyCellular Biochemistry

Publications per year

2004–2023

17

Publications

17

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

Anna Galkin, Jonathan S. Melnick, Sung Joon Kim et al. · Proceedings of the National Academy of Sciences · 2006 · 375 citations · Full text

Drug Target, Immunology, Cell Death +22

Preclinical Evaluation of Rapeseed, Raspberry, and Pine Bark Phenolics for Health Related Effects

Satu Vuorela, Kari Kreander, Maarit Karonen et al. · Journal of Agricultural and Food Chemistry · 2005 · 139 citations

Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles

Päivi Tammela, Leena Laitinen, Anna Galkin et al. · Archives of Biochemistry and Biophysics · 2004 · 128 citations

Proteinlipid Interaction, Biochemistry, Medicine +6

A genomic screen identifies TYRO3 as a MITF regulator in melanoma

Shoutian Zhu, Heiko Wurdak, Yan Wang et al. · Proceedings of the National Academy of Sciences · 2009 · 94 citations · Full text

Engineering, Cell Death, Malignant Melanoma +16

Epithelial membrane protein-1 is a biomarker of gefitinib resistance

Anjali Jain, Charles Tindell, Isett Laux et al. · Proceedings of the National Academy of Sciences · 2005 · 88 citations · Full text

Gefitinib Resistance, Cancer Biology, Tumor Biology +16

Rows per page

1–5 of 17